| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,671,000 | 3,303,000 | 3,415,000 | 4,286,000 | | Cost of Revenue | 1,159,000 | 1,784,000 | 386,000 | 6,973,000 | | | Gross Profit | 2,512,000 | 1,519,000 | 3,029,000 | (2,687,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,178,000 | 413,000 | 2,012,000 | (4,181,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 367,000 | 355,000 | 345,000 | 353,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 967,000 | 751,000 | 672,000 | 1,141,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,000 | 135,000 | 23,000 | 25,000 | | Earnings Before Interest And Taxes | 981,000 | 886,000 | 695,000 | 1,166,000 | | Interest Expense | 156,000 | 150,000 | 141,000 | 127,000 | | Income Before Tax | 825,000 | 736,000 | 554,000 | 1,039,000 | | Income Tax Expense | 308,000 | 268,000 | 192,000 | 378,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 517,000 | 468,000 | 362,000 | 661,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 517,000 | 468,000 | 362,000 | 661,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $517,000 | $468,000 | $362,000 | $661,000 |
|
0.07% Nasdaq 
Income Statement
